Skip to content

Potential new drug target may protect against certain neurodegenerative diseases

March 21, 2015

Penn Medicine researchers have discovered that hypermethylation – the epigenetic ability to turn down or turn off a bad gene implicated in 10 to 30 percent of patients with Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Degeneration (FTD) – serves as a protective barrier inhibiting the development …

Source: medicalxpress.com

Epigenetic intervention may slow the progression of ALS.

See on Scoop.itLong Life

Advertisements
No comments yet

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: